Best TWAS P=6.27e-10 · Best GWAS P=1.74e-09 conditioned to 0.273
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Heart Atrial Appendage | MED19 | 0.11 | 0.14 | lasso | 1 | 0.14 | 6.0e-07 | 5.9 | -5.9 | 3.2e-09 | -0.97 | 0.01 | 0.99 | FALSE |
2 | GTEx | Pancreas | MED19 | 0.10 | 0.08 | lasso | 3 | 0.02 | 5.0e-02 | 6.0 | -6.0 | 2.1e-09 | -0.99 | 0.01 | 0.90 | FALSE |
3 | GTEx | Skin Sun Exposed Lower leg | MED19 | 0.15 | 0.11 | lasso | 7 | 0.09 | 1.3e-07 | 5.9 | -5.6 | 2.1e-08 | -0.98 | 0.01 | 0.99 | FALSE |
4 | GTEx | Stomach | MED19 | 0.10 | 0.04 | lasso | 7 | 0.09 | 6.8e-05 | 5.8 | -6.2 | 6.3e-10 | -0.90 | 0.02 | 0.90 | TRUE |
5 | GTEx | Vagina | MED19 | 0.26 | 0.03 | lasso | 10 | 0.06 | 1.5e-02 | -2.5 | -5.5 | 4.2e-08 | -0.65 | 0.03 | 0.75 | FALSE |
6 | YFS | Blood | ZDHHC5 | 0.06 | 0.07 | enet | 20 | 0.07 | 1.2e-22 | 5.9 | 6.0 | 1.7e-09 | 0.96 | 0.01 | 0.99 | FALSE |
7 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | MED19 | 0.07 | 0.01 | blup | 26 | 0.05 | 7.4e-05 | -4.2 | -5.8 | 8.3e-09 | -0.74 | 0.03 | 0.88 | FALSE |
8 | The Cancer Genome Atlas | Breast Invasive Carcinoma | MED19 | 0.05 | 0.03 | enet | 7 | 0.05 | 1.3e-10 | 5.8 | -6.1 | 1.1e-09 | -0.84 | 0.01 | 0.99 | FALSE |
9 | The Cancer Genome Atlas | Colon Adenocarcinoma | TMX2 | 0.07 | 0.06 | lasso | 1 | 0.05 | 5.0e-04 | 5.9 | 5.9 | 2.9e-09 | 0.99 | 0.00 | 0.91 | FALSE |
10 | The Cancer Genome Atlas | Esophageal Carcinoma | MED19 | 0.10 | 0.06 | lasso | 4 | 0.02 | 5.4e-02 | 6.0 | -6.0 | 1.7e-09 | -1.00 | 0.00 | 0.85 | FALSE |
11 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | MED19 | 0.03 | 0.01 | lasso | 2 | 0.02 | 1.9e-03 | 5.8 | -5.8 | 7.1e-09 | -0.81 | 0.01 | 0.65 | FALSE |
12 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | MED19 | 0.09 | 0.05 | lasso | 2 | 0.07 | 9.2e-05 | -4.2 | -5.6 | 1.7e-08 | -0.72 | 0.03 | 0.81 | FALSE |
13 | The Cancer Genome Atlas | Lung Adenocarcinoma | MED19 | 0.05 | 0.02 | blup | 26 | 0.03 | 6.0e-05 | 5.9 | -6.1 | 1.2e-09 | -0.85 | 0.01 | 0.99 | FALSE |
14 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | MED19 | 0.03 | 0.02 | lasso | 1 | 0.01 | 1.8e-02 | 5.9 | -5.9 | 3.2e-09 | -0.97 | 0.00 | 0.86 | FALSE |
15 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | MED19 | 0.13 | 0.06 | blup | 26 | 0.13 | 4.7e-06 | -4.2 | -5.8 | 8.4e-09 | -0.75 | 0.05 | 0.82 | FALSE |
16 | The Cancer Genome Atlas | Prostate Adenocarcinoma | MED19 | 0.07 | 0.05 | blup | 26 | 0.05 | 4.4e-06 | -4.2 | -5.4 | 7.4e-08 | -0.68 | 0.44 | 0.50 | FALSE |
17 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | MED19 | 0.10 | 0.04 | blup | 26 | 0.03 | 3.6e-02 | -4.2 | -5.4 | 6.9e-08 | -0.67 | 0.02 | 0.38 | FALSE |
18 | The Cancer Genome Atlas | Thyroid Carcinoma | MED19 | 0.10 | 0.05 | blup | 26 | 0.09 | 3.8e-09 | -4.2 | -5.7 | 9.4e-09 | -0.77 | 0.08 | 0.92 | FALSE |
19 | The Cancer Genome Atlas | Thyroid Carcinoma | SERPING1 | 0.06 | 0.03 | blup | 52 | 0.04 | 6.3e-05 | 4.8 | -5.2 | 2.7e-07 | -0.69 | 0.06 | 0.86 | FALSE |